1. | | Not yet recruiting | Acupuncture for Women's Health Conditions Conditions: Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms |
2. | | Recruiting | Self-hypnotic Relaxation Therapy During Invasive Procedures Conditions: Uterine Neoplasms; Leiomyoma |
3. | | Not yet recruiting | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells Conditions: Cervical Cancer; high-grade squamous intraepithelial lesion |
4. | | Recruiting | RAD001 in Recurrent Endometrial Cancer Condition: Endometrial Cancer |
5. | | Not yet recruiting | Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
6. | | Recruiting | Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix Conditions: cervical squamous cell carcinoma; recurrent cervical cancer; stage III cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer |
7. | | Not yet recruiting | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer Conditions: recurrent endometrial cancer; endometrial adenocarcinoma; stage III endometrial cancer; stage IV endometrial cancer |
8. | | Recruiting | Stress and the Immune Response in Women with Cervical Cancer Condition: Cervix Neoplasms |
9. | | Recruiting | Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer Condition: Cervical Cancer |
10. | | Recruiting | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
11. | | Recruiting | Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears Condition: Cervical Cancer |
12. | | Recruiting | Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix Conditions: stage IVB cervical cancer; recurrent cervical cancer; cervical squamous cell carcinoma |
13. | | Recruiting | Healing Touch and Relaxation Therapies in Cervical Cancer Patients Condition: Cervix Neoplasms |
14. | | Not yet recruiting | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Conditions: Cervical Cancer; high-grade squamous intraepithelial lesion |
15. | | Recruiting | SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia Condition: Cervical Cancer |
16. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma Conditions: uterine carcinosarcoma; recurrent uterine sarcoma |
17. | | Recruiting | Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix Conditions: stage 0 cervical cancer; high-grade squamous intraepithelial lesion |
18. | | Recruiting | CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condition: Endometrial Cancer |
19. | | Recruiting | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage I cervical cancer |
20. | | Recruiting | Tariquidar and Docetaxel to Treat Patients with Lung, Ovarian, and Cervical Cancer Conditions: Lung Neoplasms; Ovarian Neoplasms; Cervix Neoplasms |
21. | | Recruiting | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer Condition: Cervical Cancer |
22. | | Recruiting | Healing Touch and Immunity in Advanced Cervical Cancer Patients Condition: Cervical Cancer |
23. | | Recruiting | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; recurrent cervical cancer; ... |
24. | | Recruiting | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus Condition: Endometrial Cancer |
25. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
26. | | Recruiting | SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia Condition: Cervical Cancer |
27. | | Recruiting | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer Conditions: recurrent cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer; cervical adenosquamous cell carcinoma; ... |
28. | | Not yet recruiting | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer Conditions: cervical adenocarcinoma; Cervical Cancer; cervical squamous cell carcinoma |
29. | | Recruiting | Vaginal Changes and Sexual Function in Patients With Cervical Cancer Conditions: sexuality and reproductive issues; stage IB cervical cancer |
30. | | Recruiting | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma |
31. | | Recruiting | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage IIB cervical cancer; ... |
32. | | Recruiting | Epoetin beta in Treating Anemia in Patients With Cervical Cancer Conditions: Anemia; Cervical Cancer |
33. | | Recruiting | Pilot Study of ZD1839 (Iressa, Gefitinib) in Patients with Advanced Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, or Cervical Cancer Conditions: Ovarian Neoplasms; Cervix Neoplasms |
34. | | Recruiting | Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; uterine leiomyosarcoma; uterine sarcoma |
35. | | Recruiting | Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
36. | | Recruiting | Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? Conditions: Anemia; Cervix Neoplasms |
37. | | Recruiting | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer Conditions: recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma |
38. | | Recruiting | Chemotherapy Followed By Surgery Compared With Radiation Therapy Plus Chemotherapy in Treating Patients With Stage IB or Stage II Cervical Cancer Conditions: stage IB cervical cancer; stage IIB cervical cancer; stage IIA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ... |
39. | | Recruiting | Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma Conditions: adult soft tissue sarcoma; uterine leiomyosarcoma; uterine sarcoma |
40. | | Recruiting | Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer Conditions: Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2) |
41. | | Recruiting | Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
42. | | Recruiting | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ... |
43. | | Recruiting | Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
44. | | Recruiting | Radiation Therapy and Cisplatin With or Without Amifostine in Treating Patients With Stage IIIB or Stage IVA Cancer of the Cervix Conditions: radiation toxicity; stage III cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ... |
45. | | Recruiting | Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer Conditions: stage IV endometrial cancer; recurrent endometrial cancer |
46. | | Recruiting | Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Conditions: stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer; endometrial adenocarcinoma |
47. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; endometrial adenoacanthoma; ... |
48. | | Recruiting | Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer Conditions: Cervical Cancer; Vaginal Cancer |
49. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma |
50. | | Recruiting | Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia Condition: Cervical Cancer |